Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dumitru Moldovan

Showing results (11-20 of 27) with videos related to

Pageof 3
Sort By:
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|October 30, 2016
Assessment of inhibitory antibodies in patients with hereditary angioedema treated with plasma-derived C1 inhibitorHenriette Farkas, Lilian Varga, Dumitru Moldovan, et al.
The Journal of Allergy and Clinical Immunology. in Practice|February 15, 2015
Recombinant human-C1 inhibitor is effective and safe for repeat hereditary angioedema attacksH Henry Li, Dumitru Moldovan, Jonathan A Bernstein, et al.
The American Journal of Medicine|July 4, 2012
Clinical impact of peripheral attacks in hereditary angioedema patientsAndy Kusuma, Anurag Relan, André C Knulst, et al.
International Archives of Allergy and Immunology|June 30, 2017
Preventing Hereditary Angioedema Attacks in Children Using Cinryze®: Interim Efficacy and Safety Phase 3 FindingsEmel Aygören-Pürsün, Daniel Soteres, Dumitru Moldovan, et al.
Pediatric Allergy and Immunology : Official Publication of the European Society of Pediatric Allergy and Immunology|April 18, 2019
Recombinant human C1 esterase inhibitor treatment for hereditary angioedema attacks in childrenAvner Reshef, Vesna Grivcheva-Panovska, Aharon Kessel, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|November 30, 2011
Randomized placebo-controlled trial of the bradykinin B₂ receptor antagonist icatibant for the treatment of acute attacks of hereditary angioedema: the FAST-3 trialWilliam R Lumry, H Henry Li, Robyn J Levy, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|January 29, 2014
Recombinant human C1-esterase inhibitor relieves symptoms of hereditary angioedema attacks: phase 3, randomized, placebo-controlled trialMarc A Riedl, Jonathan A Bernstein, Henry Li, et al.
Pediatric Allergy and Immunology : Official Publication of the European Society of Pediatric Allergy and Immunology|April 11, 2019
A randomized trial of human C1 inhibitor prophylaxis in children with hereditary angioedemaEmel Aygören-Pürsün, Daniel F Soteres, Sandra A Nieto-Martinez, et al.
Lancet (London, England)|July 30, 2017
Recombinant human C1 esterase inhibitor for prophylaxis of hereditary angio-oedema: a phase 2, multicentre, randomised, double-blind, placebo-controlled crossover trialMarc A Riedl, Vesna Grivcheva-Panovska, Dumitru Moldovan, et al.
The Journal of Allergy and Clinical Immunology. in Practice|January 26, 2019
Fixed-Dose Subcutaneous C1-Inhibitor Liquid for Prophylactic Treatment of C1-INH-HAE: SAHARA Randomized StudyWilliam R Lumry, Inmaculada Martinez-Saguer, William H Yang, et al.
Pageof 3

Showing results (11-20 of 27) with videos related to

Sort By:
Pageof 3
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|October 30, 2016
Assessment of inhibitory antibodies in patients with hereditary angioedema treated with plasma-derived C1 inhibitorHenriette Farkas, Lilian Varga, Dumitru Moldovan, et al.
The Journal of Allergy and Clinical Immunology. in Practice|February 15, 2015
Recombinant human-C1 inhibitor is effective and safe for repeat hereditary angioedema attacksH Henry Li, Dumitru Moldovan, Jonathan A Bernstein, et al.
The American Journal of Medicine|July 4, 2012
Clinical impact of peripheral attacks in hereditary angioedema patientsAndy Kusuma, Anurag Relan, André C Knulst, et al.
International Archives of Allergy and Immunology|June 30, 2017
Preventing Hereditary Angioedema Attacks in Children Using Cinryze®: Interim Efficacy and Safety Phase 3 FindingsEmel Aygören-Pürsün, Daniel Soteres, Dumitru Moldovan, et al.
Pediatric Allergy and Immunology : Official Publication of the European Society of Pediatric Allergy and Immunology|April 18, 2019
Recombinant human C1 esterase inhibitor treatment for hereditary angioedema attacks in childrenAvner Reshef, Vesna Grivcheva-Panovska, Aharon Kessel, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|November 30, 2011
Randomized placebo-controlled trial of the bradykinin B₂ receptor antagonist icatibant for the treatment of acute attacks of hereditary angioedema: the FAST-3 trialWilliam R Lumry, H Henry Li, Robyn J Levy, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|January 29, 2014
Recombinant human C1-esterase inhibitor relieves symptoms of hereditary angioedema attacks: phase 3, randomized, placebo-controlled trialMarc A Riedl, Jonathan A Bernstein, Henry Li, et al.
Pediatric Allergy and Immunology : Official Publication of the European Society of Pediatric Allergy and Immunology|April 11, 2019
A randomized trial of human C1 inhibitor prophylaxis in children with hereditary angioedemaEmel Aygören-Pürsün, Daniel F Soteres, Sandra A Nieto-Martinez, et al.
Lancet (London, England)|July 30, 2017
Recombinant human C1 esterase inhibitor for prophylaxis of hereditary angio-oedema: a phase 2, multicentre, randomised, double-blind, placebo-controlled crossover trialMarc A Riedl, Vesna Grivcheva-Panovska, Dumitru Moldovan, et al.
The Journal of Allergy and Clinical Immunology. in Practice|January 26, 2019
Fixed-Dose Subcutaneous C1-Inhibitor Liquid for Prophylactic Treatment of C1-INH-HAE: SAHARA Randomized StudyWilliam R Lumry, Inmaculada Martinez-Saguer, William H Yang, et al.
Pageof 3